Diana
New member
- Joined
- May 30, 2006
- Messages
- 2
- Reason
- PALS
- Country
- US
- State
- New York
- City
- Putnam Valley
MDA Research | FDA to Allow Ceftriaxone Study
FDA to Allow Ceftriaxone Study
After more than a year’s delay, during which the Food and Drug Administration received additional data showing the drug was safe to give intravenously to amyotrophic lateral sclerosis (ALS) patients for several months, a trial of the antibiotic ceftriaxone is slated to begin this summer.
Ceftriaxone, used to treat neurologic infections, may have benefit in ALS by enhancing a chemical recycling process in the nervous system. It will be tested in some 40 centers, according to neurologist Merit Cudkowicz, an MDA research grantee at Massachusetts General Hospital in Boston
FDA to Allow Ceftriaxone Study
After more than a year’s delay, during which the Food and Drug Administration received additional data showing the drug was safe to give intravenously to amyotrophic lateral sclerosis (ALS) patients for several months, a trial of the antibiotic ceftriaxone is slated to begin this summer.
Ceftriaxone, used to treat neurologic infections, may have benefit in ALS by enhancing a chemical recycling process in the nervous system. It will be tested in some 40 centers, according to neurologist Merit Cudkowicz, an MDA research grantee at Massachusetts General Hospital in Boston
Last edited by a moderator: